St. Jude Medical, Inc. ($STJ) Cautious Buy or Hold to $68 Confident Investor Rating: Fair

Company name St. Jude Medical, Inc.
Stock ticker STJ
Live stock price [stckqut]STJ[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Poor
EPS growth Fair
P/E growth Good
EBIT growth Poor

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $65.79
Target stock price (averages with growth) $80.45
Target stock price (averages with no growth) $71.36
Target stock price (manual assumptions) $67.23

The following company description is from Google Finance: http://www.google.com/finance?q=stj

St. Jude Medical, Inc. (St. Jude) develops, manufactures and distributes cardiovascular medical devices. Its principal products in each therapy area are: Cardiac Rhythm Management - tachycardia implantable cardioverter defibrillator systems (ICDs) and bradycardia pacemaker systems (pacemakers); Cardiovascular - vascular products, which include vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories, and structural heart products, which include heart valve replacement and repair products and structural heart defect devices; Atrial Fibrillation - electrophysiology (EP) introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems, and Neuromodulation - neurostimulation products, which include spinal cord and deep brain stimulation devices. In August 2013, St. Jude Medical Inc announced the acquisition of Endosense SA.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in St. Jude Medical, Inc. as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

For owners of my book, "The Confident Investor" I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.